Molecular credentialing of rodent bladder carcinogenesis models.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerIdentification of gene expression signature modulated by nicotinamide in a mouse bladder cancer modelCD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.Loss of SPARC in bladder cancer enhances carcinogenesis and progression.Neoplasia: the second decade.ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.Modelling bladder cancer in mice: opportunities and challenges.Biological similarities between murine chemical-induced and natural human bladder carcinogenesisFinding mouse models of human lymphomas and leukemia's using the Jackson laboratory mouse tumor biology database.Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma.Experimental rat bladder urothelial cell carcinoma models.Experimental animal model and RNA interference: a promising association for bladder cancer research.The War on Cancer rages on.RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.Development of Urinary Bladder Pre-Neoplasia by Schistosoma haematobium Eggs and Chemical Carcinogen in Mice.Animal models for bladder cancer: The model establishment and evaluation (Review).SOX2 Is a Marker for Stem-like Tumor Cells in Bladder CancerIntravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer.A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma.Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer.Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
P2860
Q24628746-CF54FF7F-0F87-46F8-AE36-47A47A75FF0AQ28477425-06358D59-44BB-4E3C-92BE-B967FE56F9BAQ30418726-652CCB63-D8EA-49A2-9832-3756758FB804Q30422650-20301E08-27AC-4B27-BBE2-8BF42B1575CEQ30484000-63203596-D845-4A24-944E-EBD5A413BBB3Q33635341-8831C30B-6A00-45C2-A92B-B37CE13442D8Q33711371-AB4C4899-8009-4ECE-BFF7-C7A66094229CQ33920324-BFDA68C8-E5C1-4111-8B02-D78FC0E69BCFQ34123241-03A6F03A-8895-4006-BA4C-064CCD794B13Q34365942-717F5B5B-5C75-4032-836E-951F494DD4FFQ35251869-EB61814C-C092-4335-9A4F-4A04FE57563BQ35285703-CAA232AF-7150-45B9-8297-D70DA2314BB1Q36216682-787C5BEF-4F71-4447-8E67-E511A5507C95Q36372990-2C5B44EE-3354-47CF-BA71-DBE8D34821F7Q36865011-96D34960-A094-4099-9C89-E6D17655BD34Q37063904-C4796377-C144-4FE0-9DE1-BE6574B5CA87Q37088006-9B95B896-5606-4BB1-A385-953321252E1AQ37222356-3DDEC5DF-09CE-4322-A4EE-C5B13D3D2B10Q37392045-DB72D75F-60C9-4228-83DF-24630601F112Q37478602-22F3431B-29D2-4FBA-8C9B-8D9B0A3C31B0Q37688331-7837D831-438A-4E86-98B6-F7958CE0A7F3Q37720577-EEAFC7EF-4404-41F5-8FB1-D8774AE1EEB5Q38383646-074AD8A9-0291-49DB-8B8A-5CD20093C030Q38632090-702D38EF-8421-4F54-A3E7-4107D67945F5Q38739860-1FBA2483-F54A-4AF0-A733-0B5B03BD6FE9Q39717326-895CCA70-0388-43F9-AA8A-710D17C06ED4Q39826217-9B254D56-859D-4DB2-822F-879966B9F038Q41339763-3874AF0E-EF0B-4436-BA76-4B23B5D2C5E4Q41619824-C9113FF4-25B0-46CE-9887-4DC8D2B1568AQ49594373-E0B7CF76-E17C-461C-A75F-E95A6A9F42ADQ55397522-DFB4AF77-D6FA-4A5A-80A1-A066C1295C6A
P2860
Molecular credentialing of rodent bladder carcinogenesis models.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Molecular credentialing of rodent bladder carcinogenesis models.
@ast
Molecular credentialing of rodent bladder carcinogenesis models.
@en
type
label
Molecular credentialing of rodent bladder carcinogenesis models.
@ast
Molecular credentialing of rodent bladder carcinogenesis models.
@en
prefLabel
Molecular credentialing of rodent bladder carcinogenesis models.
@ast
Molecular credentialing of rodent bladder carcinogenesis models.
@en
P2093
P2860
P356
P1433
P1476
Molecular credentialing of rodent bladder carcinogenesis models.
@en
P2093
Dan Theodorescu
Paul D Williams
P2860
P304
P356
10.1593/NEO.08432
P577
2008-08-01T00:00:00Z